Evidence for the Existence of Receptor—Receptor Interactions in the Central Nervous System. Studies on the Regulation of Monoamine Receptors by Neuropeptides
Substance P (SP) (10−8 M) can rapidly reduce the affinity and increase the density of 3H-5-HT binding sites in spinal cord membranes.
CCK-8 and CCK-4 (10−8 M) can rapidly and differentially change the characteristics of 3H-spiperone striatal binding sites linked to DA receptors of the D2 type. CCK-4 increase and CCK-8 reduce the number of striatal binding sites for 3H-spiperone, indicating for the first time separate CCK-4 binding sites.
CCK-4 (10−8 M) but not CCK-8 (10−8 M) can rapidly reduce the affinity and increase the number of the 3H-spiperone binding sites linked to 5-HT receptors of the dorsal cerebral cortex of rats. CCK-8 (10−8 M) only produces a trend for a small increase in the Bmax values of these receptors. These results again imply the existence of separate CCK-4 binding sites in this case in the cerebral cortex.
Glutamate (10−6 M), but not N-methyl-D-aspartate (10−6 M) can rapidly change the characteristics of the 3H-N-propylnorapomorphine (3H-NPA) binding sites in striatal membranes of rats. Glutamate (10−6 M) increases the density and especially reduces the affinity of the 3H-NPA binding sites, which label D2 and D3 types of DA receptors.
Taken together the present findings give evidence that neuropeptide receptors and glutamate receptors can in vitro rapidly modulate the characteristics of different types of DA and 5-HT receptors by way of receptor—receptor interactions at the comodulate level or at the local circuit level. It is hypothesized that these receptor—receptor interactions are of importance for the encoding of short-term memory.
Unable to display preview. Download preview PDF.
- Agnati, L. F., Fuxe, K., Benfenati, F., Calza, L., Battistini, N., Ögren, S.-O.: Receptor—receptor interactions: Possible new mechanisms for the action of some antidepressant drugs. For: Frontiers in Neuropsychiatric Research, CINP, Satellite symposium, Corfu, Greece, June 28–30. New York: Macmillan. 1982a.Google Scholar
- Agnati, L. F., Fuxe, K., Benfenati, F., Zini, I., Hökfelt, T.: On the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of 3H-5-HT binding sites. Acta Physiol. Scand. (in press, 1982b).Google Scholar
- Frey, P.: Cholecystokinin in rat brain. Determination by HPLC/RIA. Brain Res. (in press, 1982).Google Scholar
- Fuxe, K., Agnati, L. F., Benfenati, F., Cimino, M., Algeri, S., Hökfelt, T., Mutt, V.: Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: Evidence for increased affinity and reduction of the number of binding sites. Acta Physiol. Scand. 113, 567–569 (1981).Google Scholar
- Fuxe, K., Andersson, K., Schwarcz, R., A gnati, L. F., Pérez de la Mora, P., Hökfelt, T., Goldstein, M., Ferland, L., Possani, L., Tapia, R.: Studies on different types of dopamine nerve terminals in the forebrain and their possible interactions with hormones and with neurons containing GABA, glutamate and opioid peptides. In: Advances in Neurology, Vol. 24, pp. 199–214. New York: Raven Press. 1979.Google Scholar
- Fuxe, K., Fredholm, B., Agnati, L. F., Ögren, S.-0., Everitt, B.J., Jonsson, G., Gustafsson, J.-A.: Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders. Pharmacol. 16, 99–134 (1978).Google Scholar
- Fuxe, K., Hökfelt, T., Olson, L., Ungerstedt, U.: Central monoaminergic pathways with emphasis on their regulation of the so-called “extrapyramidal motor system”. Pharmac. Ther. 3, 169–210 (1977).Google Scholar
- Fuxe, K., Ögren, S.-O., Agnati, L. F., Benfenati, F., Cavicchioli, L., Fredholm, B., Andersson, K., Farabegoli, C., Eneroth, P.: Regional variations in 5-HT receptor populations and in 3H-imipramine binding sites in their responses to chronic antidepressant treatment. For: Frontiers in Neuropsychiatric Research, CINP, Satellite symposium, Corfu, Greece, June 28–30. New York: Macmillan. 1982.Google Scholar
- Lefkowitz, R.J.: Radioligand binding studies of adrenergic receptors. In: Central Adrenaline Neurons. Basic Aspects and Their Role in Cardiovascular Functions, pp. 291–301. Oxford: Pergamon Press. 1979.Google Scholar
- Leysen, J. E.: 3H-apomorphine receptors in various rat brain regions: a study of specific and nonspecific binding and the influence of chronic neuroleptic treatment. In: Long Term Effects of Neuroleptics (Adv. Biochem. Psychopharmacol., Vol. 24), p. 123. New York: Raven Press. 1980.Google Scholar
- Nelson, D. L., Herber A., Bourgoin, S., Glowinski,J., Hanon, M.: Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Molec. Pharmacol. 14, 983–996 (1978).Google Scholar
- Seeman, P.: Dopamine Receptors. In: Pharmacological Reviews, Vol. 32, No.3, pp. 229–313. Baltimore: Williams and Wilkins. 1980.Google Scholar
- Seeman, P., List, S.: Dopamine receptors and dopaminergic supersensitivity. In: Advances in Pharmacology and Therapeutics II (Neurotransmitters Receptors, Vol.2), p. 42. New York: Pergamon Press. 1981.Google Scholar
- Seyfried, C. A., Fuxe, K., Wolf, H.-P., Agnati, L. F.: Demonstration of a new type of dopamine receptor agonist: an indolyl-3-butylamine. Actions at intact versus supersensitive dopamine receptors in the rat forebrain. Acta Physiol. Scand. (in press, 1982).Google Scholar